Medical Care Technologies (OTC: MDCE) Unveils Bold Vision for Mobile Self-Care Innovation

Rhea-AI Summary

Medical Care Technologies (OTC: MDCE) has launched its official website, showcasing its strategic focus on AI-powered mobile health diagnostics and self-care solutions. The company has developed several patent-pending innovations leveraging smartphone technology for health monitoring, including an AI Wound-Healing Monitor, Mental Health Scanner, Health Risk Estimator, and Mole Lineage Tracker.

These technologies originated from MDCE's subsidiary, Real Game Used, adapting their image authentication software for healthcare applications. The company plans to launch a beta app in 2026 and is pursuing multiple patent applications to advance its mission of making preventive healthcare accessible through mobile devices.

Positive

• None.

Negative

• Products still in development phase with no current revenue
• Beta app launch not until 2026 indicating long path to commercialization
• Trading on OTC Pink Market which typically indicates higher risk

News Market Reaction

+33.33%

1 alert

+33.33% News Effect

On the day this news was published, MDCE gained 33.33%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Empowering Everyday Health Through AI: MDCE Launches Official Site

MESA, AZ / ACCESS Newswire / July 7, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), a health technology company focused on AI-powered self-care and mobile diagnostics, is proud to announce the launch of its official website at www.medicalcaretechnologies.com. The new platform highlights the company's strategic mission to deliver transformative, AI-driven health solutions accessible via smartphone-bringing early detection and preventive medicine directly into the hands of users worldwide.

The company's growing portfolio of patent-pending innovations includes:

• AI Wound-Healing Monitor: Uses sequential smartphone images to assess chronic wound recovery with clinical-level precision.

• AI Micro-Expression Mental Health Scanner: Detects early signs of depression, anxiety, and PTSD using facial pattern analysis from short selfie videos.

• Facial Age-Based Health Risk Estimator: Estimates biological age and predicts chronic disease risk from a single facial photo.

• AI Mole Lineage Tracker: Tracks changes in skin lesions over time using full-body photo mapping to support melanoma detection.

Each technology was originally developed under MDCE's subsidiary, Real Game Used, whose image analysis engine was adapted from authentication software used in elite memorabilia verification. The company is now applying that high-resolution, image-intelligent foundation to solve critical problems in healthcare, chronic disease monitoring, and early risk detection.

"Our goal is simple but ambitious as this project has been in the works for over a year," said a spokesperson for MDCE. "We're building powerful health tools that anyone can use-from their pocket-before symptoms become crises. With plans for multiple patent applications underway and a planned beta app launch in 2026, we believe our model has the potential to redefine self-care and reshape the future of AI in preventive medicine."

Medical Care Technologies Inc. trades on the OTC Pink Market under the ticker MDCE and operates with a growing pipeline of strategic partnerships. The company invites investors, partners, and healthcare innovators to explore its newly launched digital home.

Visit: www.medicalcaretechnologies.com

About Medical Care Technologies Inc. (OTC: MDCE)

Medical Care Technologies is an AI-driven health innovation company focused on delivering mobile-first, diagnostic-grade wellness tools. By combining deep learning, computer vision, and personalized analytics, MDCE empowers individuals to monitor their health using only a smartphone. The company's mission is to bring preventive care to life through accessible, intelligent technology.

Safe Harbor Statement:

This press release may contain forward-looking statements subject to risks and uncertainties. Actual results may differ materially from those expressed or implied. The company undertakes no obligation to update forward-looking statements, except as required by law.

Media & Investor Contact:
Infinite Auctions / Medical Care Technologies
info@medicalcaretechnologies.com
www.medicalcaretechnologies.com

SOURCE: Medical Care Technologies Inc.

View the original press release on ACCESS Newswire

FAQ

What AI health technologies is Medical Care Technologies (MDCE) developing?

MDCE is developing four main AI technologies: 1) AI Wound-Healing Monitor for chronic wound assessment, 2) Mental Health Scanner for detecting psychological conditions, 3) Facial Age-Based Health Risk Estimator, and 4) AI Mole Lineage Tracker for melanoma detection.

When will MDCE's health monitoring app be available to the public?

MDCE plans to launch its beta app in 2026, though specific timing details haven't been announced.

How does MDCE's technology work with smartphones?

MDCE's technology uses smartphone cameras to capture images and videos, which are then analyzed by AI algorithms for various health assessments including wound healing, mental health indicators, aging markers, and skin lesion changes.

What is the background of MDCE's AI technology?

The technology was originally developed by MDCE's subsidiary, Real Game Used, as an image authentication software for memorabilia verification, and has been adapted for healthcare applications.

Where can investors find more information about Medical Care Technologies (MDCE)?

Investors can visit MDCE's newly launched website at www.medicalcaretechnologies.com for more information about the company and its technologies.